Optimizing FOLFIRINOX tolerability in patients with colorectal cancer through dosing irinotecan in the morning for men and in the afternoon for women.

Francis Lévi,Annabelle Ballesta,Abdoulaye Karaboué,Qi Huang,Christian Focan,Philippe Chollet,Mohamed Bouchahda,René Adam,Carlo Garufi,Pasquale F. Innominato

Optimizing FOLFIRINOX tolerability in patients with colorectal cancer through dosing irinotecan in the morning for men and in the afternoon for women.

2020

Francis Lévi
Annabelle Ballesta
Abdoulaye Karaboué
Qi Huang
Christian Focan
Philippe Chollet
Mohamed Bouchahda
René Adam
Carlo Garufi
Pasquale F. Innominato

120Background: Irinotecan (IRI) toxicity was worse in female (F) than in male (M) patients (pts) on FOLFIRI for metastatic colorectal cancer (MCC). This finding could reflect different optimal admi...

Keywords:

Morning
FOLFIRINOX
Irinotecan
Internal medicine
Oncology
Medicine
Dosing
Physical therapy
Colorectal cancer
Tolerability
Toxicity
FOLFIRI

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations